Cleared Abbreviated

K254033 - Ceribell Instant EEG Headset (FDA 510(k) Clearance)

Feb 2026
Decision
55d
Days
Class 2
Risk

K254033 is an FDA 510(k) clearance for the Ceribell Instant EEG Headset. This device is classified as a Electrode, Cutaneous (Class II - Special Controls, product code GXY).

Submitted by Ceribell, Inc. (Sunnyvale, US). The FDA issued a Cleared decision on February 9, 2026, 55 days after receiving the submission on December 16, 2025.

This device falls under the Neurology FDA review panel. Regulated under 21 CFR 882.1320.

Submission Details

510(k) Number K254033 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received December 16, 2025
Decision Date February 09, 2026
Days to Decision 55 days
Submission Type Abbreviated
Review Panel Neurology (NE)
Summary Summary PDF

Device Classification

Product Code GXY - Electrode, Cutaneous
Device Class Class II - Special Controls
CFR Regulation 21 CFR 882.1320